FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Gurny

Research Profile

Chemicals & Drugs

Concepts & Ideas

Objects

Nanoparticles

Procedures

Photochemotherapy

Co-author Network

Publications

TOP 3
Marta Rodriguez-Aller; Jean-Luc Veuthey; Robert Gurny; Davy Guillarme
Coupling ultra high-pressure liquid chromatography with mass spectrometry: Constraints and possible applications.
Marieke Veurink; Constantin J Pournaras; Lutz Asmus; Lena Bagnewski; Robert Gurny; Arnd Heiligenhaus; Maren Hennig; Béatrice Kaufmann; Efstratios Mendrinos; Michael Möller
Design and in vitro assessment of L-lactic acid-based copolymers as prodrug and carrier for intravitreal sustained L-lactate release to reverse retinal arteriolar occlusions.
Gaëlle Vacher; Robert Gurny; Matthias D Kaeser; Christian Moser; Gerrit Borchard
Recent Advances in Mucosal Immunization Using Virus-like Particles.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Gurny (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marta Rodriguez-Aller; Jean-Luc Veuthey; Robert Gurny; Davy Guillarme
Coupling ultra high-pressure liquid chromatography with mass spectrometry: Constraints and possible applications.
Journal of chromatography. A 2013;1292():2-18.
2013: Marieke Veurink; Constantin J Pournaras; Lutz Asmus; Lena Bagnewski; Robert Gurny; Arnd Heiligenhaus; Maren Hennig; Béatrice Kaufmann; Efstratios Mendrinos; Michael Möller
Design and in vitro assessment of L-lactic acid-based copolymers as prodrug and carrier for intravitreal sustained L-lactate release to reverse retinal arteriolar occlusions.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2013;49(2):233-40.
2013: Gaëlle Vacher; Robert Gurny; Matthias D Kaeser; Christian Moser; Gerrit Borchard
Recent Advances in Mucosal Immunization Using Virus-like Particles.
Molecular pharmaceutics 2013;10(5):1596-609.
2013: Marieke Veurink; Yvonne Westermaier; Robert Gurny; Leonardo Scapozza
Breaking the aggregation of the monoclonal antibody bevacizumab (avastin®) by dexamethasone phosphate: insights from molecular modelling and asymmetrical flow field-flow fractionation.
Pharmaceutical research 2013;30(4):1176-87.
2013: Simone Eperon; Robert Gurny; Marta Rodriguez-Aller; Konstantinos Balaskas; Yan Guex-Crosier
A new drug delivery system inhibits uveitis in an animal model after cataract surgery.
International journal of pharmaceutics 2013;443(1-2):254-61.
2013: Lutz R Asmus; Robert Gurny; Béatrice Kaufmann; Wolfgang Koechling; Louise Melander; Grégoire Schwach; Jean-Christophe Tille; Kerstin Vessman; Torsten Weiss; Michael Möller
In vivo biocompatibility, sustained-release and stability of triptorelin formulations based on a liquid, degradable polymer.
Journal of controlled release : official journal of the Controlled Release Society 2013;165(3):199-206.
2012: S de Valence; J-P Giliberto; Robert Gurny; Wojciech Mrowczynski; Jean-Christophe Tille; Beat H Walpoth; M Möller
Advantages of bilayered vascular grafts for surgical applicability and tissue regeneration.
Acta biomaterialia 2012;8(11):3914-20.
2012: Doris Gabriel; Robert Gurny; Norbert Lange; Hubert van den Bergh; Maria Fernanda Zuluaga; Veronique Chobaz-Peclat; Nathalie Busso
Thrombin-sensitive dual fluorescence imaging and therapeutic agent for detection and treatment of synovial inflammation in murine rheumatoid arthritis.
Journal of controlled release : official journal of the Controlled Release Society 2012;163(2):178-86.
2012: Lutz R Asmus; Robert Gurny; Béatrice Kaufmann; Louise Melander; Grégoire Schwach; Torsten Weiss; Michael Möller
Single processing step toward injectable sustained-release formulations of Triptorelin based on a novel degradable semi-solid polymer.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2012;81(3):591-9.
2012: Claudia Di Tommaso; Robert Gurny; Jean-Claude Jeanny; Francine Behar-Cohen; Jean-Louis Bourges; Alicia Torriglia; Gregory Trubitsyn; Fatemeh Valamanesh; Michael Möller
Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2012;81(2):257-64.
2012: E Patois; S E J Bell; M A H Capelle; Robert Gurny; I A Larmour; C Palais; Tudor Arvinte
Ultraviolet Resonance Raman spectroscopy used to study formulations of salmon calcitonin, a starch-peptide conjugate and TGF-β3.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2012;81(2):392-8.
2012: Aliya O Kasimova; Andrea Cristiani; Andrea Danani; Robert Gurny; Karine Mondon; Giovanni M Pavan; Leonardo Scapozza; Michael Möller
Validation of a novel molecular dynamics simulation approach for lipophilic drug incorporation into polymer micelles.
The journal of physical chemistry. B 2012;116(14):4338-45.
2012: Claudia Di Tommaso; Pascal Furrer; Robert Gurny; Florence Miller; Marta Rodriguez-Aller; Fatemeh Valamanesh; Francine Behar-Cohen; Michael Möller
A novel cyclosporin a aqueous formulation for dry eye treatment: in vitro and in vivo evaluation.
Investigative ophthalmology & visual science 2012;53(4):2292-9.
2012: M Rodriguez-Aller; Serge Rudaz; C Stella; F Valamanesh; Jean-Luc Veuthey; F Behar-Cohen; C Di Tommaso; I El Zaoui; Pascal Furrer; Davy Guillarme; B Kaufmann; Robert Gurny
In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2012;80(3):544-52.
2012: Sarra de Valence; Robert Gurny; Michael Möller; Wojciech Mrowczynski; Damiano Mugnai; Jean-Christophe Tille; Beat H Walpoth
Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement model.
Biomaterials 2012;33(1):38-47.
2011: Lutz R Asmus; Robert Gurny; Michael Möller
Solutions as solutions--synthesis and use of a liquid polyester excipient to dissolve lipophilic drugs and formulate sustained-release parenterals.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2011;79(3):584-91.
2011: Claudia Di Tommaso; Pascal Furrer; Robert Gurny; Francine Behar-Cohen; Alicia Torriglia; Michael Möller
Ocular biocompatibility of novel Cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers.
International journal of pharmaceutics 2011;416(2):515-24.
2011: Robert Gurny; Jean Christophe Leroux
Use of nanoparticles for pharmaceutical dosage forms.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2011;79(1):1-2.
2011: Robert Gurny; Wolfgang Friess
Unmet needs in protein formulation science.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2011;78(2):183.
2011: Filippo Mulinacci; Emilie Poirier; Martinus A H Capelle; Robert Gurny; Tudor Arvinte
Enhanced physical stability of human calcitonin after methionine oxidation.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2011;78(2):229-38.
2011: Marieke Veurink; Cinzia Stella; Cyrus Tabatabay; Constantin J Pournaras; Robert Gurny
Association of ranibizumab (Lucentis®) or bevacizumab (Avastin®) with dexamethasone and triamcinolone acetonide: an in vitro stability assessment.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2011;78(2):271-7.
2011: C Di Tommaso; Francine Behar-Cohen; Robert Gurny; M Möller
Colloidal systems for the delivery of cyclosporin A to the anterior segment of the eye.
Annales pharmaceutiques françaises 2011;69(2):116-23.
2011: Karine Mondon; Magali Zeisser-Labouèbe; Robert Gurny; Michael Möller
MPEG-hexPLA micelles as novel carriers for hypericin, a fluorescent marker for use in cancer diagnostics.
Photochemistry and photobiology 2011;87(2):399-407.
2011: Lutz R Asmus; Robert Gurny; Michael Möller
Solutions for lipophilic drugs: a biodegradable polymer acting as solvent, matrix, and carrier to solve drug delivery issues.
The International journal of artificial organs 2011;34(2):238-42.
2011: Filippo Mulinacci; Martinus A H Capelle; Robert Gurny; Alex F Drake; Tudor Arvinte
Stability of human growth hormone: influence of methionine oxidation on thermal folding.
Journal of pharmaceutical sciences 2011;100(2):451-63.
2011: Ludmila Luca; Anne-Laure Rougemont; Beat H Walpoth; Ludovic Boure; Andrea Tami; James M Anderson; Olivier Jordan; Robert Gurny
Injectable rhBMP-2-loaded chitosan hydrogel composite: osteoinduction at ectopic site and in segmental long bone defect.
Journal of biomedical materials research. Part A 2011;96(1):66-74.
2011: K Mondon; M Zeisser-Labouèbe; Robert Gurny; M Möller
Novel cyclosporin A formulations using MPEG-hexyl-substituted polylactide micelles: a suitability study.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2011;77(1):56-65.
2011: Filippo Mulinacci; Steven E J Bell; Martinus A H Capelle; Robert Gurny; Tudor Arvinte
Oxidized recombinant human growth hormone that maintains conformational integrity.
Journal of pharmaceutical sciences 2011;100(1):110-22.
2010: Ludmila Luca; Anne-Laure Rougemont; Beat H Walpoth; Robert Gurny; Olivier Jordan
The effects of carrier nature and pH on rhBMP-2-induced ectopic bone formation.
Journal of controlled release : official journal of the Controlled Release Society 2010;147(1):38-44.
2010: A Cirstoiu-Hapca; Franz Buchegger; Norbert Lange; L Bossy; Robert Gurny; Florence Delie
Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice.
Journal of controlled release : official journal of the Controlled Release Society 2010;144(3):324-31.
2010: Ludmila Luca; Martinus A H Capelle; Gia Machaidze; Tudor Arvinte; Olivier Jordan; Robert Gurny
Physical instability, aggregation and conformational changes of recombinant human bone morphogenetic protein-2 (rhBMP-2).
International journal of pharmaceutics 2010;391(1-2):48-54.
2010: Marie Gaumet; Robert Gurny; Florence Delie
Interaction of biodegradable nanoparticles with intestinal cells: the effect of surface hydrophilicity.
International journal of pharmaceutics 2010;390(1):45-52.
2010: Claudia Di Tommaso; Caterina Como; Robert Gurny; Michael Möller
Investigations on the lyophilisation of MPEG-hexPLA micelle based pharmaceutical formulations.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2010;40(1):38-47.
2010: Fanny Guillaumie; Pascal Furrer; Olivia Felt-Baeyens; Birgit L Fuhlendorff; Søren Nymand; Peter Westh; Robert Gurny; Khadija Schwach-Abdellaoui
Comparative studies of various hyaluronic acids produced by microbial fermentation for potential topical ophthalmic applications.
Journal of biomedical materials research. Part A 2010;92(4):1421-30.
2010: Robert Gurny; Karsten Mäder
Imaging tools for pharmaceutical development.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2010;74(1):1.
2010: Pascal Furrer; Robert Gurny
Recent advances in confocal microscopy for studying drug delivery to the eye: concepts and pharmaceutical applications.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2010;74(1):33-40.
2010: Vincent Malaterre; Maireadh Pedersen; Joerg Ogorka; Robert Gurny; Nicoletta Loggia; Philip F Taday
Terahertz pulsed imaging, a novel process analytical tool to investigate the coating characteristics of push-pull osmotic systems.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2010;74(1):21-5.
2009: Nicolas Fotinos; Juro Mikulic; Maruska Convert; Marino Andres Campo; Jean-Claude Piffaretti; Robert Gurny; Norbert Lange
5-ALA derivative-mediated photoinactivation of Propionibacterium acnes.
Journal of dermatological science 2009;56(3):214-6.
2009: Vincent Malaterre; Joerg Ogorka; Nicoletta Loggia; Robert Gurny
Oral osmotically driven systems: 30 years of development and clinical use.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2009;73(3):311-23.
2009: Emilie Patois; Suzanne Osorio-da Cruz; Jean-Christophe Tille; Beat H Walpoth; Robert Gurny; Olivier Jordan
Novel thermosensitive chitosan hydrogels: in vivo evaluation.
Journal of biomedical materials research. Part A 2009;91(2):324-30.
2009: A Cirstoiu-Hapca; Franz Buchegger; L Bossy; M Kosinski; Robert Gurny; Florence Delie
Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2009;38(3):230-7.
2009: Francesco Innocente; Delia Mandracchia; Erman Pektok; Benjamin Nottelet; Jean-Christophe Tille; Sarra de Valence; Giuseppe Faggian; Alessandro Mazzucco; Afksendiyos Kalangos; Robert Gurny; Michael Moeller; Beat H Walpoth
Paclitaxel-eluting biodegradable synthetic vascular prostheses: a step towards reduction of neointima formation?
Circulation 2009;120(11 Suppl):S37-45.
2009: Doris Gabriel; Nathalie Busso; Alexander So; Hubert van den Bergh; Robert Gurny; Norbert Lange
Thrombin-sensitive photodynamic agents: a novel strategy for selective synovectomy in rheumatoid arthritis.
Journal of controlled release : official journal of the Controlled Release Society 2009;138(3):225-34.
2009: Angelica Vargas; Norbert Lange; Tudor Arvinte; Radovan Cerny; Robert Gurny; Florence Delie
Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activity.
Journal of drug targeting 2009;17(8):599-609.
2009: Magali Zeisser-Labouèbe; Marc Mattiuzzo; Norbert Lange; Robert Gurny; Florence Delie
Quenching-induced deactivation of photosensitizer by nanoencapsulation to improve phototherapy of cancer.
Journal of drug targeting 2009;17(8):619-26.
2009: Vincent Malaterre; Joerg Ogorka; Nicoletta Loggia; Robert Gurny
Approach to design push-pull osmotic pumps.
International journal of pharmaceutics 2009;376(1-2):56-62.
2009: B Nottelet; E Pektok; D Mandracchia; Jean-Christophe Tille; Beat H Walpoth; Robert Gurny; M Möller
Factorial design optimization and in vivo feasibility of poly(epsilon-caprolactone)-micro- and nanofiber-based small diameter vascular grafts.
Journal of biomedical materials research. Part A 2009;89(4):865-75.
2009: Vincent Malaterre; Joerg Ogorka; Nicoletta Loggia; Robert Gurny
Evaluation of the tablet core factors influencing the release kinetics and the loadability of push-pull osmotic systems.
Drug development and industrial pharmacy 2009;35(4):433-9.
2009: Marie Gaumet; Robert Gurny; Florence Delie
Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2009;36(4-5):465-73.
2009: Barthélemy Demeule; Caroline Palais; Gia Machaidze; Robert Gurny; Tudor Arvinte
New methods allowing the detection of protein aggregates: a case study on trastuzumab.
mAbs 2009;1(2):142-50.
2009: Magali Zeisser-Labouèbe; Florence Delie; Robert Gurny; Norbert Lange
Screening of nanoparticulate delivery systems for the photodetection of cancer in a simple and cost-effective model.
Nanomedicine (London, England) 2009;4(2):135-43.
2009: Magali Zeisser-Labouèbe; Florence Delie; Robert Gurny; Norbert Lange
Benefits of nanoencapsulation for the hypercin-mediated photodetection of ovarian micrometastases.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2009;71(2):207-13.
2009: Esther Furrer; Marianne Berdugo; Cinzia Stella; Francine Behar-Cohen; Robert Gurny; Ulrich Feige; Peter Lichtlen; David M Urech
Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
Investigative ophthalmology & visual science 2009;50(2):771-8.
2009: Vincent Malaterre; Hendrik Metz; Joerg Ogorka; Robert Gurny; Nicoletta Loggia; Karsten Mäder
Benchtop-magnetic resonance imaging (BT-MRI) characterization of push-pull osmotic controlled release systems.
Journal of controlled release : official journal of the Controlled Release Society 2009;133(1):31-6.
2008: Erman Pektok; Benjamin Nottelet; Jean-Christophe Tille; Robert Gurny; Afksendiyos Kalangos; Michael Moeller; Beat H Walpoth
Degradation and healing characteristics of small-diameter poly(epsilon-caprolactone) vascular grafts in the rat systemic arterial circulation.
Circulation 2008;118(24):2563-70.
2008: Marianne Berdugo Polak; Fatemeh Valamanesh; Olivia Felt; Alicia Torriglia; Jean-Claude Jeanny; Jean-Louis Bourges; Patrice Rat; Aoife Thomas-Doyle; David BenEzra; Robert Gurny; Francine Behar-Cohen
Controlled delivery of 5-chlorouracil using poly(ortho esters) in filtering surgery for glaucoma.
Investigative ophthalmology & visual science 2008;49(7):2993-3003.
2008: Sabine Collaud; Qian Peng; Robert Gurny; Norbert Lange
Thermosetting gel for the delivery of 5-aminolevulinic acid esters to the cervix.
Journal of pharmaceutical sciences 2008;97(7):2680-90.
2008: Angelica Vargas; Michael Eid; Mohammed Fanchaouy; Robert Gurny; Florence Delie
In vivo photodynamic activity of photosensitizer-loaded nanoparticles: formulation properties, administration parameters and biological issues involved in PDT outcome.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;69(1):43-53.
2008: Marie Gaumet; Angelica Vargas; Robert Gurny; Florence Delie
Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;69(1):1-9.
2008: Nicolas Fotinos; Maruska Convert; Jean-Claude Piffaretti; Robert Gurny; Norbert Lange
Effects on gram-negative and gram-positive bacteria mediated by 5-aminolevulinic Acid and 5-aminolevulinic acid derivatives.
Antimicrobial agents and chemotherapy 2008;52(4):1366-73.
2008: Simone Eperon; Leila Bossy-Nobs; I K Petropoulos; Robert Gurny; Yan Guex-Crosier
A biodegradable drug delivery system for the treatment of postoperative inflammation.
International journal of pharmaceutics 2008;352(1-2):240-7.
2008: Martinus A H Capelle; Robert Gurny; Tudor Arvinte
High throughput methods to characterize protein permeation and release.
International journal of pharmaceutics 2008;350(1-2):272-8.
2008: Stefanie Siepe; Barbara Lueckel; Andrea Kramer; Angelika Ries; Robert Gurny
Assessment of tailor-made HPMC-based matrix minitablets comprising a weakly basic drug compound.
Drug development and industrial pharmacy 2008;34(1):46-52.
2008: Yannic B Schuetz; Robert Gurny; Olivier Jordan
A novel thermoresponsive hydrogel based on chitosan.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;68(1):19-25.
2007: Jean-Louis Bourges; E Touchard; L Kowalczuk; Marianne Berdugo; A Thomas-Doyle; Amélie Bochot; A Gomez; Frédéric Azan; Robert Gurny; Francine Behar-Cohen
[Drug delivery systems for intraocular applications].
Journal français d'ophtalmologie 2007;30(10):1070-88.
2007: Sabine Collaud; T Warloe; Olivier Jordan; Robert Gurny; Norbert Lange
Clinical evaluation of bioadhesive hydrogels for topical delivery of hexylaminolevulinate to Barrett's esophagus.
Journal of controlled release : official journal of the Controlled Release Society 2007;123(3):203-10.
2007: Angelica Vargas; Magali Zeisser-Labouèbe; Norbert Lange; Robert Gurny; Florence Delie
The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems.
Advanced drug delivery reviews 2007;59(11):1162-76.
2007: Marie Gaumet; Robert Gurny; Florence Delie
Fluorescent biodegradable PLGA particles with narrow size distributions: preparation by means of selective centrifugation.
International journal of pharmaceutics 2007;342(1-2):222-30.
2007: Frederic Lallemand; Emmanuel Varesio; Olivia Felt-Baeyens; Leila Bossy; Gérard Hopfgartner; Robert Gurny
Biological conversion of a water-soluble prodrug of cyclosporine A.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2007;67(2):555-61.
2007: Marino A Campo; Doris Gabriel; Pavel Kucera; Robert Gurny; Norbert Lange
Polymeric photosensitizer prodrugs for photodynamic therapy.
Photochemistry and photobiology 2007;83(4):958-65.
2007: Doris Gabriel; Marino A Campo; Robert Gurny; Norbert Lange
Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes.
Bioconjugate chemistry 2007;18(4):1070-7.
2007: Ines Baer; Robert Gurny; Pierre Margot
NIR analysis of cellulose and lactose--application to ecstasy tablet analysis.
Forensic science international 2007;167(2-3):234-41.
2007: Maria-Fernanda Zuluaga; Carolina Mailhos; Gregory Robinson; David T Shima; Robert Gurny; Norbert Lange
Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degeneration.
Investigative ophthalmology & visual science 2007;48(4):1767-72.
2007: A Cirstoiu-Hapca; Leila Bossy-Nobs; Franz Buchegger; Robert Gurny; Florence Delie
Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles.
International journal of pharmaceutics 2007;331(2):190-6.
2007: Martinus A H Capelle; Robert Gurny; Tudor Arvinte
High throughput screening of protein formulation stability: practical considerations.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2007;65(2):131-48.
2007: Barthélemy Demeule; Robert Gurny; Tudor Arvinte
Detection and characterization of protein aggregates by fluorescence microscopy.
International journal of pharmaceutics 2007;329(1-2):37-45.
2007: Barthélemy Demeule; M Jayne Lawrence; Alex F Drake; Robert Gurny; Tudor Arvinte
Characterization of protein aggregation: the case of a therapeutic immunoglobulin.
Biochimica et biophysica acta 2007;1774(1):146-53.
2007: Thomas Trimaille; Robert Gurny; Michael Möller
Poly(hexyl-substituted lactides): novel injectable hydrophobic drug delivery systems.
Journal of biomedical materials research. Part A 2007;80(1):55-65.
2006: Magali Zeisser-Labouèbe; Norbert Lange; Robert Gurny; Florence Delie
Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer.
International journal of pharmaceutics 2006;326(1-2):174-81.
2006: Jean-Louis Bourges; Carole Bloquel; A Thomas; F Froussart; Amélie Bochot; Frédéric Azan; Robert Gurny; David BenEzra; Francine Behar-Cohen
Intraocular implants for extended drug delivery: therapeutic applications.
Advanced drug delivery reviews 2006;58(11):1182-202.
2006: Olivia Felt-Baeyens; Simone Eperon; Paolo Mora; D Limal; Serge Sagodira; Pascal Breton; B Simonazzi; Leila Bossy-Nobs; Yan Guex-Crosier; Robert Gurny
Biodegradable scleral implants as new triamcinolone acetonide delivery systems.
International journal of pharmaceutics 2006;322(1-2):6-12.
2006: Luca Costantino; Francesca Gandolfi; Leila Bossy-Nobs; Giovanni Tosi; Robert Gurny; Francesco Rivasi; Maria Angela Vandelli; Flavio Forni
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures.
Biomaterials 2006;27(26):4635-45.
2006: Thomas Trimaille; Karine Mondon; Robert Gurny; Michael Möller
Novel polymeric micelles for hydrophobic drug delivery based on biodegradable poly(hexyl-substituted lactides).
International journal of pharmaceutics 2006;319(1-2):147-54.
2006: Nicolas Fotinos; Marino A Campo; Florence Popowycz; Robert Gurny; Norbert Lange
5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives.
Photochemistry and photobiology 2006;82(4):994-1015.
2006: Stefanie Siepe; Barbara Lueckel; Andrea Kramer; Angelika Ries; Robert Gurny
Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pH.
International journal of pharmaceutics 2006;316(1-2):14-20.
2006: Stefanie Siepe; Werner Herrmann; Hans-Hubert Borchert; Barbara Lueckel; Andrea Kramer; Angelika Ries; Robert Gurny
Microenvironmental pH and microviscosity inside pH-controlled matrix tablets: an EPR imaging study.
Journal of controlled release : official journal of the Controlled Release Society 2006;112(1):72-8.
2006: Barthélemy Demeule; Robert Gurny; Tudor Arvinte
Where disease pathogenesis meets protein formulation: renal deposition of immunoglobulin aggregates.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2006;62(2):121-30.
2006: Jean-Louis Bourges; F Lallemand; E Agla; Kamel Besseghir; Jean-Maurice Dumont; David BenEzra; Robert Gurny; Francine Behar-Cohen
Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
Molecular vision 2006;12():1461-6.
2006: Cung An Nguyen; Yvette Niamien Konan-Kouakou; Eric Allémann; Eric Doelker; David Quintanar-Guerrero; Hatem Fessi; Robert Gurny
Preparation of surfactant-free nanoparticles of methacrylic acid copolymers used for film coating.
AAPS PharmSciTech 2006;7(3):63.
2006: Sabine Collaud; Patrice Jichlinski; A Marti; Danièla Aymon; Robert Gurny; Norbert Lange
An open pharmacokinetic study of hexylaminolevulinate-induced photodiagnosis after intravesical administration.
Drugs in R&D 2006;7(3):173-86.
2006: Leila Nobs; Franz Buchegger; Robert Gurny; Eric Allémann
Biodegradable nanoparticles for direct or two-step tumor immunotargeting.
Bioconjugate chemistry 2006;17(1):139-45.
2005: Frederic Lallemand; Philippe Perottet; Olivia Felt-Baeyens; Werner Kloeti; Florence Philippoz; Judith Marfurt; Kamel Besseghir; Robert Gurny
A water-soluble prodrug of cyclosporine A for ocular application: a stability study.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2005;26(1):124-9.
2005: Frederic Lallemand; Pascal Furrer; Olivia Felt-Baeyens; Marianne Gex-Fabry; Jean-Maurice Dumont; Kamel Besseghir; Robert Gurny
A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics.
International journal of pharmaceutics 2005;295(1-2):7-14.
2005: Paolo Mora; Simone Eperon; Olivia Felt-Baeyens; Robert Gurny; Serge Sagodira; Pascal Breton; Yan Guex-Crosier
Trans-scleral diffusion of triamcinolone acetonide.
Current eye research 2005;30(5):355-61.
2005: Yvette Niamien Konan-Kouakou; R Boch; Robert Gurny; Eric Allémann
In vitro and in vivo activities of verteporfin-loaded nanoparticles.
Journal of controlled release : official journal of the Controlled Release Society 2005;103(1):83-91.
2005: J Berger; Marianne Reist; A Chenite; Olivia Felt-Baeyens; Joachim M Mayer; Robert Gurny
Pseudo-thermosetting chitosan hydrogels for biomedical application.
International journal of pharmaceutics 2005;288(2):197-206.
2005: J Berger; Marianne Reist; A Chenite; Olivia Felt-Baeyens; Joachim M Mayer; Robert Gurny
Pseudo-thermosetting chitosan hydrogels for biomedical application.
International journal of pharmaceutics 2005;288(1):17-25.
2005: Frederic Lallemand; Olivia Felt-Baeyens; Serge Rudaz; A R Hamel; F Hubler; R Wenger; Manfred Mutter; Kamel Besseghir; Robert Gurny
Conversion of cyclosporine A prodrugs in human tears vs rabbits tears.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2005;59(1):51-6.
2004: Angelica Vargas; Bernadette Pegaz; Elodie Debefve; Yvette Niamien Konan-Kouakou; Norbert Lange; Jean-Pierre Ballini; Hubert van den Bergh; Robert Gurny; Florence Delie
Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos.
International journal of pharmaceutics 2004;286(1-2):131-45.
2004: Leila Nobs; Franz Buchegger; Robert Gurny; Eric Allémann
Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targeting.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;58(3):483-90.
2004: Leila Nobs; Franz Buchegger; Robert Gurny; Eric Allémann
Current methods for attaching targeting ligands to liposomes and nanoparticles.
Journal of pharmaceutical sciences 2004;93(8):1980-92.
2004: Luma Baydoun; Pascal Furrer; Robert Gurny; Christel C Müller-Goymann
New surface-active polymers for ophthalmic formulations: evaluation of ocular tolerance.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;58(1):169-75.
2004: Grégoire Schwach; Nathalie Oudry; Jean-Pierre Giliberto; Pierre Broqua; Martin Lück; Hans Lindner; Robert Gurny
Biodegradable PLGA microparticles for sustained release of a new GnRH antagonist: part II. In vivo performance.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;57(3):441-6.
2004: J Berger; Marianne Reist; Joachim M Mayer; O Felt; Robert Gurny
Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;57(1):35-52.
2004: J Berger; Marianne Reist; Joachim M Mayer; O Felt; N A Peppas; Robert Gurny
Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;57(1):19-34.
2003: Grégoire Schwach; Nathalie Oudry; Sophie Delhomme; Martin Lück; Hans Lindner; Robert Gurny
Biodegradable microparticles for sustained release of a new GnRH antagonist--part I: Screening commercial PLGA and formulation technologies.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2003;56(3):327-36.
2003: Frederic Lallemand; Olivia Felt-Baeyens; Kamel Besseghir; Francine Behar-Cohen; Robert Gurny
Cyclosporine A delivery to the eye: a pharmaceutical challenge.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2003;56(3):307-18.
2003: Cung An Nguyen; Eric Allémann; Grégoire Schwach; Eric Doelker; Robert Gurny
Synthesis of a novel fluorescent poly(D,L-lactide) end-capped with 1-pyrenebutanol used for the preparation of nanoparticles.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2003;20(2):217-22.
2003: Suzanne Einmahl; Stéphanie Ponsart; Riad Antoine Bejjani; François D'Hermies; Michèle Savoldelli; Jorge Heller; Cyrus Tabatabay; Robert Gurny; Francine Behar-Cohen
Ocular biocompatibility of a poly(ortho ester) characterized by autocatalyzed degradation.
Journal of biomedical materials research. Part A 2003;67(1):44-53.
2003: Jean-Louis Bourges; Sandrine Gautier; Florence Delie; Riad Antoine Bejjani; Jean-Claude Jeanny; Robert Gurny; David BenEzra; Francine Behar-Cohen
Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles.
Investigative ophthalmology & visual science 2003;44(8):3562-9.
2003: Yvette Niamien Konan; J Chevallier; Robert Gurny; Eric Allémann
Encapsulation of p-THPP into nanoparticles: cellular uptake, subcellular localization and effect of serum on photodynamic activity.
Photochemistry and photobiology 2003;77(6):638-44.
2003: Cung An Nguyen; Eric Allémann; Grégoire Schwach; Eric Doelker; Robert Gurny
Cell interaction studies of PLA-MePEG nanoparticles.
International journal of pharmaceutics 2003;254(1):69-72.
2003: Yvette Niamien Konan; Myriam Berton; Robert Gurny; Eric Allémann
Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2003;18(3-4):241-9.
2003: Leila Nobs; Franz Buchegger; Robert Gurny; Eric Allémann
Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methods.
International journal of pharmaceutics 2003;250(2):327-37.
2003: Yvette Niamien Konan; Radovan Cerny; Joselyne Favet; Myriam Berton; Robert Gurny; Eric Allémann
Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2003;55(1):115-24.
2002: V Baeyens; Olivia Felt-Baeyens; Sandrine Rougier; S Pheulpin; Bernard Boisramé; Robert Gurny
Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI) for the treatment of external ocular infections in dogs.
Journal of controlled release : official journal of the Controlled Release Society 2002;85(1-3):163-8.
2002: Khadija Schwach-Abdellaoui; Marinette Moreau; Marc Schneider; Bernard Boisramć; Robert Gurny
Controlled delivery of metoclopramide using an injectable semi-solid poly(ortho ester) for veterinary application.
International journal of pharmaceutics 2002;248(1-2):31-7.
2002: J Helle; John Barr; Steven Y Ng; Hui-Rong Shen; Khadija Schwach-Abdellaoui; Robert Gurny; Nathalie Vivien-Castioni; Pierre-Jean Loup; Pierre Baehni; A Mombelli
Development and applications of injectable poly(ortho esters) for pain control and periodontal treatment.
Biomaterials 2002;23(22):4397-404.
2002: Jorge Heller; John Barr; Steven Y Ng; Khadija Schwach Abdellauoi; Robert Gurny
Poly(ortho esters): synthesis, characterization, properties and uses.
Advanced drug delivery reviews 2002;54(7):1015-39.
2002: Suzanne Einmahl; Michèle Savoldelli; François D'Hermies; Cyrus Tabatabay; Robert Gurny; Francine Behar-Cohen
Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye.
Investigative ophthalmology & visual science 2002;43(5):1533-9.
2002: Pascal Furrer; Joachim M Mayer; Robert Gurny
Ocular tolerance of preservatives and alternatives.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2002;53(3):263-80.
2002: Yvette Niamien Konan; Robert Gurny; Eric Allémann
State of the art in the delivery of photosensitizers for photodynamic therapy.
Journal of photochemistry and photobiology. B, Biology 2002;66(2):89-106.
2002: Yvette Niamien Konan; Robert Gurny; Eric Allémann
Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles.
International journal of pharmaceutics 2002;233(1-2):239-52.
2002: Jorge Heller; John Barr; Steve Ng; Hui-Rong Shen; Robert Gurny; Khadija Schwach-Abdelaoui; Alexandra Rothen-Weinhold; Marco van de Weert
Development of poly(ortho esters) and their application for bovine serum albumin and bupivacaine delivery.
Journal of controlled release : official journal of the Controlled Release Society 2002;78(1-3):133-41.
2002: Khadija Schwach-Abdellaoui; Pierre-Jean Loup; Nathalie Vivien-Castioni; Andrea Mombelli; Pierre Baehni; John Barr; Jorge Heller; Robert Gurny
Bioerodible injectable poly(ortho ester) for tetracycline controlled delivery to periodontal pockets: preliminary trial in humans.
AAPS pharmSci 2002;4(4):E20.
2002: Pascal Furrer; Joachim M Mayer; Bernard Plazonnet; Robert Gurny
Ocular tolerance of absorption enhancers in ophthalmic preparations.
AAPS pharmSci 2002;4(1):E2.
2001: Suzanne Einmahl; Sergio Capancioni; Khadija Schwach-Abdellaoui; M Moeller; Francine Behar-Cohen; Robert Gurny
Therapeutic applications of viscous and injectable poly(ortho esters).
Advanced drug delivery reviews 2001;53(1):45-73.
2001: Myriam Berton; Priscilla Turelli; Didier Trono; Cy A Stein; Eric Allémann; Robert Gurny
Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles.
Pharmaceutical research 2001;18(8):1096-101.
2001: Khadija Schwach-Abdellaoui; A Monti; John Barr; Jorge Heller; Robert Gurny
Optimization of a novel bioerodible device based on auto-catalyzed poly(ortho esters) for controlled delivery of tetracycline to periodontal pocket.
Biomaterials 2001;22(12):1659-66.
2001: Alexandra Rothen-Weinhold; Khadija Schwach-Abdellaoui; John Barr; Steven Y Ng; Hui-Rong Shen; Robert Gurny; Jorge Heller
Release of BSA from poly(ortho ester) extruded thin strands.
Journal of controlled release : official journal of the Controlled Release Society 2001;71(1):31-7.
2001: Florence Delie; Robert Gurny; A Zimmer
Fluorescence correlation spectroscopy for the characterisation of drug delivery systems.
Biological chemistry 2001;382(3):487-90.
2001: Suzanne Einmahl; Francine Behar-Cohen; François D'Hermies; Serge Rudaz; Cyrus Tabatabay; G Renard; Robert Gurny
A new poly(ortho ester)-based drug delivery system as an adjunct treatment in filtering surgery.
Investigative ophthalmology & visual science 2001;42(3):695-700.
2001: Florence Delie; Myriam Berton; Eric Allémann; Robert Gurny
Comparison of two methods of encapsulation of an oligonucleotide into poly(D,L-lactic acid) particles.
International journal of pharmaceutics 2001;214(1-2):25-30.
2001: O Felt; V Baeyens; P Buri; Robert Gurny
Delivery of antibiotics to the eye using a positively charged polysaccharide as vehicle.
AAPS pharmSci 2001;3(4):E34.
2001: F De Jaeghere; Eric Allémann; Radovan Cerny; B Galli; A F Steulet; I Müller; H Schütz; Eric Doelker; Robert Gurny
pH-Dependent dissolving nano- and microparticles for improved peroral delivery of a highly lipophilic compound in dogs.
AAPS pharmSci 2001;3(1):E8.
2001: Pascal Furrer; J Berger; Joachim M Mayer; Robert Gurny
[A comparative study of the ocular tolerance of 3 timolol-based preparations: the influence of preservatives on ocular tolerance].
Journal français d'ophtalmologie 2001;24(1):13-9.
2000: Pascal Furrer; Bernard Plazonnet; Joachim M Mayer; Robert Gurny
Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants.
International journal of pharmaceutics 2000;207(1-2):89-98.
2000: M Zignani; Suzanne Einmahl; V Baeyens; Emmanuel Varesio; Jean-Luc Veuthey; J Anderson; Jorge Heller; Cyrus Tabatabay; Robert Gurny
A poly(ortho ester) designed for combined ocular delivery of dexamethasone sodium phosphate and 5-fluorouracil: subconjunctival tolerance and in vitro release.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2000;50(2):251-5.
2000: M Zignani; T Le Minh; Suzanne Einmahl; Cyrus Tabatabay; Jorge Heller; J M Anderson; Robert Gurny
Improved biocompatibility of a viscous bioerodible poly(ortho ester) by controlling the environmental pH during degradation.
Biomaterials 2000;21(17):1773-8.
2000: F De Jaeghere; Eric Allémann; F Kubel; B Galli; R Cozens; Eric Doelker; Robert Gurny
Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state.
Journal of controlled release : official journal of the Controlled Release Society 2000;68(2):291-8.
2000: Jorge Heller; John Barr; Steven Y Ng; Hui-Rong Shen; Khadija Schwach-Abdellaoui; Suzanne Einmahl; Alexandra Rothen-Weinhold; Robert Gurny; S Emmahl
Poly(ortho esters) - their development and some recent applications.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2000;50(1):121-8.
2000: Khadija Schwach-Abdellaoui; Nathalie Vivien-Castioni; Robert Gurny
Local delivery of antimicrobial agents for the treatment of periodontal diseases.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2000;50(1):83-99.
2000: Suzanne Einmahl; Francine Behar-Cohen; Cyrus Tabatabay; Michèle Savoldelli; François D'Hermies; Dominique Chauvaud; Jorge Heller; Robert Gurny
A viscous bioerodible poly(ortho ester) as a new biomaterial for intraocular application.
Journal of biomedical materials research 2000;50(4):566-73.
2000: O Felt; anne carrel; Pierre Baehni; P Buri; Robert Gurny
Chitosan as tear substitute: a wetting agent endowed with antimicrobial efficacy.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2000;16(3):261-70.
2000: Alexandra Rothen-Weinhold; Nathalie Oudry; Khadija Schwach-Abdellaoui; S Frutiger-Hughes; GJ Hughes; Damien Jeannerat; U Burger; Kamel Besseghir; Robert Gurny
Formation of peptide impurities in polyester matrices during implant manufacturing.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2000;49(3):253-7.
2000: F De Jaeghere; Eric Allémann; J Feijen; T Kissel; Eric Doelker; Robert Gurny
Freeze-drying and lyopreservation of diblock and triblock poly(lactic acid)-poly(ethylene oxide) (PLA-PEO) copolymer nanoparticles.
Pharmaceutical development and technology 2000;5(4):473-83.
2000: F De Jaeghere; Eric Allémann; J Feijen; T Kissel; Eric Doelker; Robert Gurny
Cellular uptake of PEO surface-modified nanoparticles: evaluation of nanoparticles made of PLA:PEO diblock and triblock copolymers.
Journal of drug targeting 2000;8(3):143-53.
2000: Nathalie Vivien-Castioni; Robert Gurny; Pierre Baehni; V Kaltsatos
Salivary fluoride concentrations following applications of bioadhesive tablets and mouthrinses.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2000;49(1):27-33.
1999: Myriam Berton; Eric Allémann; Cy A Stein; Robert Gurny
Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 1999;9(2):163-70.
1999: Alexandra Rothen-Weinhold; Kamel Besseghir; Evelyne Vuaridel; E Sublet; Nathalie Oudry; F Kubel; Robert Gurny
Injection-molding versus extrusion as manufacturing technique for the preparation of biodegradable implants.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 1999;48(2):113-21.
1999: Suzanne Einmahl; M Zignani; Emmanuel Varesio; Jorge Heller; Jean-Luc Veuthey; Cyrus Tabatabay; Robert Gurny
Concomitant and controlled release of dexamethasone and 5-fluorouracil from poly(ortho ester).
International journal of pharmaceutics 1999;185(2):189-98.
1999: F De Jaeghere; Eric Allémann; Jean-Christophe Leroux; W Stevels; J Feijen; Eric Doelker; Robert Gurny
Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptake.
Pharmaceutical research 1999;16(6):859-66.
1999: O Felt; Pascal Furrer; Joachim M Mayer; Bernard Plazonnet; P Buri; Robert Gurny
Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention.
International journal of pharmaceutics 1999;180(2):185-93.
1999: Myriam Berton; Luba Benimetskaya; Eric Allémann; Cy A Stein; Robert Gurny
Uptake of oligonucleotide-loaded nanoparticles in prostatic cancer cells and their intracellular localization.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 1999;47(2):119-23.
1999: Pascal Furrer; Joachim M Mayer; Bernard Plazonnet; Robert Gurny
Ocular tolerance of preservatives on the murine cornea.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 1999;47(2):105-12.
1999: Alexandra Rothen-Weinhold; Kamel Besseghir; Evelyne Vuaridel; E Sublet; Nathalie Oudry; Robert Gurny
Stability studies of a somatostatin analogue in biodegradable implants.
International journal of pharmaceutics 1999;178(2):213-21.
1999: Khadija Schwach-Abdellaoui; Jorge Heller; Robert Gurny
Synthesis and characterization of self-catalyzed poly(ortho-esters) based on decanediol and decanediol-lactate.
Journal of biomaterials science. Polymer edition 1999;10(3):375-89.
1998: M B Sintzel; Jorge Heller; Steven Y Ng; Cyrus Tabatabay; Khadija Schwach-Abdellaoui; Robert Gurny
In vitro drug release from self-catalyzed poly(ortho ester): case study of 5-fluorouracil.
Journal of controlled release : official journal of the Controlled Release Society 1998;55(2-3):213-8.
1998: O Felt; P Buri; Robert Gurny
Chitosan: a unique polysaccharide for drug delivery.
Drug development and industrial pharmacy 1998;24(11):979-93.
1998: V Baeyens; V Kaltsatos; B Boisrame; Marc Fathi; Robert Gurny
Evaluation of soluble Bioadhesive Ophthalmic Drug Inserts (BODI) for prolonged release of gentamicin: lachrymal pharmacokinetics and ocular tolerance.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 1998;14(3):263-72.
1998: M B Sintzel; Jorge Heller; Steven Y Ng; M S Taylor; Cyrus Tabatabay; Robert Gurny
Synthesis and characterization of self-catalyzed poly(ortho ester).
Biomaterials 1998;19(7-9):791-800.
1998: V Baeyens; V Kaltsatos; Bernard Boisramé; Emmanuel Varesio; Jean-Luc Veuthey; Marc Fathi; Luc P Balant; Marianne Gex-Fabry; Robert Gurny
Optimized release of dexamethasone and gentamicin from a soluble ocular insert for the treatment of external ophthalmic infections.
Journal of controlled release : official journal of the Controlled Release Society 1998;52(1-2):215-20.
1998: Alexandra Rothen-Weinhold; Kamel Besseghir; Y De Zelicourt; Robert Gurny
Development and evaluation in vivo of a long-term delivery system for vapreotide, a somatostatin analogue.
Journal of controlled release : official journal of the Controlled Release Society 1998;52(1-2):205-13.
1998: N V Castioni; Pierre Baehni; Robert Gurny
Current status in oral fluoride pharmacokinetics and implications for the prophylaxis against dental caries.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 1998;45(2):101-11.
1998: M Zignani; S F Bernatchez; T Le Minh; Cyrus Tabatabay; J M Anderson; Robert Gurny
Subconjunctival biocompatibility of a viscous bioerodable poly(ortho ester).
Journal of biomedical materials research 1998;39(2):277-85.
1998: A A Deshpande; J Heller; Robert Gurny
Bioerodible polymers for ocular drug delivery.
Critical reviews in therapeutic drug carrier systems 1998;15(4):381-420.
1997: Pascal Furrer; Joachim M Mayer; Robert Gurny
Confocal microscopy as a tool for the investigation of the anterior part of the eye.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 1997;13(6):559-78.
1997: Eric Allémann; P Gravel; Jean-Christophe Leroux; Luc P Balant; Robert Gurny
Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles: evidence of complement C3 component involvement.
Journal of biomedical materials research 1997;37(2):229-34.
1997: V Baeyens; Robert Gurny
Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations.
Pharmaceutica acta Helvetiae 1997;72(4):191-202.
1997: V Baeyens; Emmanuel Varesio; Jean-Luc Veuthey; Robert Gurny
Determination of dexamethasone in tears by capillary electrophoresis.
Journal of chromatography. B, Biomedical sciences and applications 1997;692(1):222-6.
1996: A Merkli; Jorge Heller; Cyrus Tabatabay; Robert Gurny
Purity and stability assessment of a semi-solid poly(ortho ester) used in drug delivery systems.
Biomaterials 1996;17(9):897-902.
1996: Jean-Christophe Leroux; Robert Cozens; J L Roesel; B Galli; Eric Doelker; Robert Gurny
pH-sensitive nanoparticles: an effective means to improve the oral delivery of HIV-1 protease inhibitors in dogs.
Pharmaceutical research 1996;13(3):485-7.
1996: G Meseguer; P Buri; Bernard Plazonnet; A Rozier; Robert Gurny
Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 1996;12(4):481-8.
1996: Vincent H L Lee; H Yamahara; Robert Gurny; M B Sintzel; M Martenet; Marianne Gex-Fabry; L Balant; Shigehiro Ohdo; S K Podder
Basis for dosing time-dependent changes in the ocular and systemic absorption of topically applied timolol.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 1996;12(2):103-13.
1995: Jean-Christophe Leroux; Robert Cozens; J L Roesel; B Galli; F Kubel; Eric Doelker; Robert Gurny
Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice.
Journal of pharmaceutical sciences 1995;84(12):1387-91.
1995: F Gurtler; V Kaltsatos; Bernard Boisramé; J Deleforge; Marianne Gex-Fabry; Luc P Balant; Robert Gurny
Ocular availability of gentamicin in small animals after topical administration of a conventional eye drop solution and a novel long acting bioadhesive ophthalmic drug insert.
Pharmaceutical research 1995;12(11):1791-5.
1995: Eric Allémann; N Brasseur; O Benrezzak; J Rousseau; S V Kudrevich; R W Boyle; Jean-Christophe Leroux; Robert Gurny; Johan E van Lier
PEG-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to EMT-6 mouse mammary tumours.
The Journal of pharmacy and pharmacology 1995;47(5):382-7.
1995: Jean-Christophe Leroux; F De Jaeghere; B Anner; Eric Doelker; Robert Gurny
An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes.
Life sciences 1995;57(7):695-703.
1995: F Lescure; Robert Gurny; Eric Doelker
In vitro and in vivo evaluation of progesterone implants based on new biodegradable poly(glutamic and glutamate esters) copolymers.
Journal of biomaterials science. Polymer edition 1995;6(9):797-807.
1994: A Merkli; Jorge Heller; Cyrus Tabatabay; Robert Gurny
Gamma sterilization of a semi-solid poly(ortho ester) designed for controlled drug delivery--validation and radiation effects.
Pharmaceutical research 1994;11(10):1485-91.
1994: S F Bernatchez; A Merkli; T L Minh; Cyrus Tabatabay; J M Anderson; Robert Gurny
Biocompatibility of a new semisolid bioerodible poly(ortho ester) intended for the ocular delivery of 5-fluorouracil.
Journal of biomedical materials research 1994;28(9):1037-46.
1994: Jean-Christophe Leroux; P Gravel; Luc P Balant; B Volet; B M Anner; Eric Allémann; Eric Doelker; Robert Gurny
Internalization of poly(D,L-lactic acid) nanoparticles by isolated human leukocytes and analysis of plasma proteins adsorbed onto the particles.
Journal of biomedical materials research 1994;28(4):471-81.
1994: G Meseguer; Robert Gurny; P Buri
In vivo evaluation of dosage forms: application of gamma scintigraphy to non-enteral routes of administration.
Journal of drug targeting 1994;2(4):269-88.
1993: Eric Allémann; Jean-Christophe Leroux; Robert Gurny; Eric Doelker
In vitro extended-release properties of drug-loaded poly(DL-lactic acid) nanoparticles produced by a salting-out procedure.
Pharmaceutical research 1993;10(12):1732-7.
1993: S F Bernatchez; A Merkli; Cyrus Tabatabay; Robert Gurny; Q H Zhao; J M Anderson; Jorge Heller
Biotolerance of a semisolid hydrophobic biodegradable poly(ortho ester) for controlled drug delivery.
Journal of biomedical materials research 1993;27(5):677-81.
1993: S F Bernatchez; Cyrus Tabatabay; Robert Gurny
Sodium hyaluronate 0.25% used as a vehicle increases the bioavailability of topically administered gentamicin.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 1993;231(3):157-61.
1993: A Merkli; Jorge Heller; Cyrus Tabatabay; Robert Gurny
Synthesis and characterization of a new biodegradable semi-solid poly(ortho ester) for drug delivery systems.
Journal of biomaterials science. Polymer edition 1993;4(5):505-16.
1992: F Lescure; Robert Gurny; Eric Doelker; J M Anderson
Long-term histopathological study of new polypeptidic biomaterials.
Biomaterials 1992;13(14):1009-11.
1990: Robert Gurny; J E Ryser; Cyrus Tabatabay; M Martenet; P Edman; O Camber
Precorneal residence time in humans of sodium hyaluronate as measured by gamma scintigraphy.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 1990;228(6):510-2.
1989: F Lescure; Robert Gurny; Eric Doelker; M L Pelaprat; D Bichon; J M Anderson
Acute histopathological response to a new biodegradable polypeptidic polymer for implantable drug delivery system.
Journal of biomedical materials research 1989;23(11):1299-313.
1989: B Gander; Robert Gurny; Eric Doelker; N A Peppas
Effect of polymeric network structure on drug release from cross-linked poly(vinyl alcohol) micromatrices.
Pharmaceutical research 1989;6(7):578-84.
1989: F Lescure; Robert Gurny; Eric Doelker; J Augustynski
[Use of principles of iontophoresis and electrophoresis for controlled release of medical substances].
Pharmaceutica acta Helvetiae 1989;64(8):210-9.
1988: H Ibrahim; P Buri; Robert Gurny
[Composition, structure and physiologic parameters of the lacrimal system; implications for the concept of ophthalmic forms].
Pharmaceutica acta Helvetiae 1988;63(6):146-54.
1987: C Bindschaedler; Robert Gurny; Eric Doelker
Osmotic water transport through cellulose acetate membranes produced from a latex system.
Journal of pharmaceutical sciences 1987;76(6):455-60.
1987: O Camber; P Edman; Robert Gurny
Influence of sodium hyaluronate on the meiotic effect of pilocarpine in rabbits.
Current eye research 1987;6(6):779-84.
1987: C Bindschaedler; Robert Gurny; Eric Doelker
Mechanically strong films produced from cellulose acetate latexes.
The Journal of pharmacy and pharmacology 1987;39(5):335-8.
1986: B Gander; Robert Gurny; Eric Doelker
[Matrices for controlled liberation by swelling of polymers. II: Preparation of drug delivery systems and analysis of liberation kinetics].
Pharmaceutica acta Helvetiae 1986;61(7):178-84.
1986: B Gander; Robert Gurny; Eric Doelker
[Matrices for controlled liberation of drugs from polymers. I. Mechanisms of the penetration of solvents into polymers].
Pharmaceutica acta Helvetiae 1986;61(5-6):130-4.
1984: Robert Gurny; J M Meyer; N A Peppas
Bioadhesive intraoral release systems: design, testing and analysis.
Biomaterials 1984;5(6):336-40.
1983: R W Korsmeyer; Robert Gurny; Eric Doelker; P Buri; N A Peppas
Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air.
Journal of pharmaceutical sciences 1983;72(10):1189-91.
1983: N A Peppas; Robert Gurny
[Relation between the structure of polymers and the controlled release of active ingredients].
Pharmaceutica acta Helvetiae 1983;58(1):2-8.
1982: C Bindschaedler; Robert Gurny
[Optimization of pharmaceutical formulations by the simplex method using a TI 59 calculator].
Pharmaceutica acta Helvetiae 1982;57(9):251-5.
1982: Robert Gurny; Eric Doelker; N A Peppas
Modelling of sustained release of water-soluble drugs from porous, hydrophobic polymers.
Biomaterials 1982;3(1):27-32.